2-(2-疏基乙基)异吲哚啉-1,3-二酮 | 4490-75-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 中文名称: 2-(2-疏基乙基)异吲哚啉-1,3-二酮
• 中文别名: 2-(2-巯基乙基)异吲哚啉-1,3-二酮
• 英文名称: N-(2-mercaptoethyl)-phthalimide
• 英文别名: 2-(2-mercaptoethyl)isoindoline-1,3-dione；Ethanethiol, 2-phthalimido-；2-(2-sulfanylethyl)isoindole-1,3-dione
• CAS: 4490-75-9
• 化学式: C₁₀H₉NO₂S
• 分子量: 207.253
• InChiKey: UHOPWFKONJYLCF-UHFFFAOYSA-N

物化性质

• 熔点：
  76 °C
• 沸点：
  344.3±25.0 °C(Predicted)
• 密度：
  1.344±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  38.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2930909090

反应信息

• 作为反应物：
  描述：

  2-(2-疏基乙基)异吲哚啉-1,3-二酮 在 肼 作用下， 生成 巯基乙胺
  参考文献：
  名称：

  Acheson, R. Morrin; Constable, Edwin C.; Wright, R. Gordon McR., Journal of Chemical Research, Miniprint, 1983, # 1, p. 101 - 132

  摘要：

  DOI：
• 作为产物：
  描述：

  N-(2-mercapto-ethyl)-phthalamic acid 生成 2-(2-疏基乙基)异吲哚啉-1,3-二酮
  参考文献：
  名称：

  Gabriel; Colman, Chemische Berichte, 1912, vol. 45, p. 1650

  摘要：

  DOI：

文献信息

• Haloguanidine compounds, pharmaceutical compositions and methods of use
  申请人：ICI Americas Inc.

  公开号：US04362728A1

  公开（公告）日：1982-12-07

  Compounds useful for inhibiting gastric acid secretion and for the treatment of peptic ulcers caused or exacerbated by gastric acidity having the following formula (I): ##STR1## in which R.sup.1 and R.sup.2, are H, C.sub.1-10 alkyl, C.sub.3-8 cycloalkyl or cycloalkylalkyl in which the alkyl part is C.sub.1-6 and the cycloalkyl part is C.sub.3-8, each of the alkyl, cycloalkyl and cycloalkylalkyls being optionally substituted by one or more halogens selected from F, Cl and Br, provided that at least one of R.sup.1 and R.sup.2 is a halogen substituted alkyl, cycloalkyl or cycloalkylalkyl and provided that there is no halogen substituent on the carbon directly attached to the nitrogen; and X, m, Y, n and R.sup.3 are as described in the specification; and the pharmaceutically-acceptable acid-addition salts thereof. Processes for producing compounds of formula (I), pharmaceutical compositions containing them, methods of utilizing such compositions and intermediates useful for synthesizing compounds of formula (I) are also described.

  用于抑制胃酸分泌和治疗由胃酸引起或加重的消化性溃疡的化合物具有以下结构式（I）：##STR1##其中R.sup.1和R.sup.2为H，C.sub.1-10烷基，C.sub.3-8环烷基或环烷基烷基，其中烷基部分为C.sub.1-6，环烷基部分为C.sub.3-8，每个烷基，环烷基和环烷基烷基可选择地被来自F、Cl和Br的一个或多个卤素取代，前提是R.sup.1和R.sup.2中至少有一个是卤素取代的烷基，环烷基或环烷基烷基，并且直接连接到氮的碳上没有卤素取代物；X，m，Y，n和R.sup.3如规范中所述；以及其药用可接受的酸加盐。还描述了制备结构式（I）化合物的方法，含有它们的药物组合物，利用这种组合物的方法以及用于合成结构式（I）化合物的中间体。
• Two-step three-component process for one-pot synthesis of 8-alkylmercaptocaffeine derivatives
  作者：M. N. Soltani Rad、S. Maghsoudi

  DOI：10.1039/c6ra17814f

  日期：——

  A highly efficient, odourless and two-step three-component process for one-pot synthesis of some 8-alkylmercaptocaffeine derivatives has been described. The catalyst-free three-component reaction of alkyl bromides, thiourea, and 8-bromocaffeine gave 8-alkylmercaptocaffeine products in excellent to quantitative yields. In addition, the impact of parameters on sample reaction is discussed.

  已经描述了一种高效，无味，两步三组分法，用于一锅合成一些8-烷基巯基咖啡因衍生物。烷基溴，硫脲和8-溴咖啡因的无催化剂三组分反应以优异的定量收率得到了8-烷基巯基咖啡因产物。此外，还讨论了参数对样品反应的影响。
• Phenyliodine(III) Diacetate/I ₂ ‐Mediated Domino Approach for Pyrrolo[1,4]Thiazines and 1,4‐Thiazines by a One‐Pot Morin Rearrangement of N,S <i>‐</i> Acetals
  作者：Fanny Danton、Mohamed Othman、Ata Martin Lawson、Ján Moncol、Alina Ghinet、Benoît Rigo、Adam Daïch

  DOI：10.1002/chem.201901111

  日期：2019.4.26

  diacetate (PIDA)/I2 combination towards Morin 1,4‐thiazine compounds has been developed starting from N,S‐acetals. The latter leads to “one‐step” regioselective methylene insertion without the need for traditional sulfoxide intermediates in good yields. The reaction involves easily accessible N,S‐acetals obtained from cost‐effective basic ketones and cysteamine as starting materials. This process ultimately

  使用phenyliodine（III）二乙酸酯（PIDA）/ I的高效多米诺变换2组合朝向莫林1,4-噻嗪化合物已经开发选自N，S开始-缩醛。后者导致“一步式”区域选择性亚甲基插入，而无需以高收率使用传统的亚砜中间体。该反应涉及方便N，S -从成本效益的基本酮和半胱胺获得作为原料缩醛。此过程最终导致与1,4-噻嗪有关的天然产物和进一步的QSAR研究所需的熔融衍生物。
• Photochemistry of phthaloylcysteine, its methyl ester and C-unprotected S-alkyl derivatives
  作者：Axel G. Griesbeck、Joachim Hirt、Wolfgang Kramer、Paul Dallakian

  DOI：10.1016/s0040-4020(98)00063-5

  日期：1998.3

  cysteine derivatives 1a-d were photochemically transformed by elimination, decarboxylation, and via electron transfer cyclization to the products 2,3,4 and 6–8. The spin selectivities of singlet and triplet pathways were investigated in acetonitrile and acetone. The excited singlets were prone to elimination and γ-H abstractions (e.g. formation of 5) whereas the triplets cyclized to thiazinoisoindoles

  N-邻苯二甲酰基半胱氨酸衍生物1a-d通过消除，脱羧和通过电子转移环化而光化学转化为产物2,3,4和6-8。在乙腈和丙酮中研究了单重态和三重态途径的自旋选择性。激发的单线态易于消除和γ-H提取（例如形成5），而三联体环化成噻嗪基异吲哚。该行为可以与正向和返回电子转移步骤相对于均质氢提取的效率相关，如半胱氨酸底物9所证明的。
• Synthesis, antiproliferative, and antimicrobial properties of novel phthalimide derivatives
  作者：Chun-Lan Chi、Lu Xu、Jun-Jie Li、Yang Liu、Bao-Quan Chen

  DOI：10.1007/s00044-021-02823-5

  日期：2022.1

  In this research, a series of new phthalimide derivatives with disulfide bonds were designed and synthesized, and their in vitro antiproliferative activities against normal cell lines L929, human cancer cells Hela, MCF-7, and A549 were assessed via the CCK-8 assay. At the same time, in vitro antimicrobial activities of all compounds were evaluated against Gram-negative Escherichia coli and Gram-positive

  本研究设计并合成了一系列具有二硫键的邻苯二甲酰亚胺衍生物，并通过CCK-8检测评估了它们对正常细胞系L929、人癌细胞Hela、MCF-7和A549的体外抗增殖活性。同时，评估了所有化合物对革兰氏阴性大肠杆菌和革兰氏阳性金黄色葡萄球菌的体外抗菌活性。初步生物测定结果表明，邻苯二甲酰亚胺6a-e、7a-e、8a-e和9a-e的一系列衍生物表现出不同程度的抗增殖活性，部分化合物显示出比阳性对照 5-氟尿嘧啶更高的抗增殖作用。化合物9b (IC 50  = 2.86 μM) 表现出对 A549 细胞的最佳增殖抑制活性。结果表明，化合物6b（IC 50  = 2.94 μM）和6c（IC 50  = 3.20 μM）对Hela细胞表现出优异的生物活性。化合物9b (IC 50  = 3.21 μM) 对 MCF-7 细胞显示出最高的抗肿瘤活性。此外，大多数目标化合物对正常细胞系 L929 具有相对